Transcript of "Self selction of p medicines the journey"
Self Selection of Pmedicines – The Journey
What we proposed and why• Outcome focussed standards• No one size fits all approach• Encourages joint decision making and meaningful discussion• Legal framework remains• Enables tailored service provisionTherefore, the draft standards did not contain a prescriptive prohibition
What we have heardFor (enabling self selection) Against (enabling self selection)• Should be safe to rely on the professional • Medicines are not ordinary items ofjudgement of pharmacists who decide what commercemedicines should be on display• Cost and time benefit • High risk, theft• Reflects that one size doesn’t fit all • Erosion of the P category• Supports informed decision making • GPhC not carrying out its role in protecting patient safety + public interest• Encourages collaboration and dialogue • Commercial managers will use the changes to ‘market’ P medicines more aggressively • Introduce inconsistencies in the availability of medicines – confusing
Our proposals• No prescriptive statement in standards• Draft compliance guidance• Compliance guidance subject to consultation and published early 2013• Until publication of compliance guidance – prohibition on self selection remainsNext steps• Draft compliance guidance
Discussion• Are you content with the proposals?• What risks, if any, do you think we need to address?• In addition to compliance guidance, what other mechanisms can we use to manage these?
A particular slide catching your eye?
Clipping is a handy way to collect important slides you want to go back to later.